News from the AI & ML world
DeeperML
@siliconangle.com
//
Retro Biosciences, a startup focused on extending human lifespan, is reportedly raising $1 billion in Series A funding. The company, backed by Sam Altman, aims to use artificial intelligence to develop therapies that could extend human life by a decade. This funding round will be used to advance their drug development programs, leveraging AI-driven healthcare research. Retro Biosciences is aiming to significantly accelerate the process of identifying new treatments.
The startup is utilizing a custom AI model developed with OpenAI called GPT-4b micro. This model is trained on data related to proteins, particularly Yamanaka factors, which are crucial for turning skin cells into stem cells. This AI is designed to enhance the effectiveness of these proteins which is a key area of focus for longevity research. Retro’s research uses a method called few-shot prompting which is intended to boost the quality of AI outputs and accelerate the pace of discovery in this complex area.
ImgSrc: d15shllkswkct0.
References :
The startup is utilizing a custom AI model developed with OpenAI called GPT-4b micro. This model is trained on data related to proteins, particularly Yamanaka factors, which are crucial for turning skin cells into stem cells. This AI is designed to enhance the effectiveness of these proteins which is a key area of focus for longevity research. Retro’s research uses a method called few-shot prompting which is intended to boost the quality of AI outputs and accelerate the pace of discovery in this complex area.
ImgSrc: d15shllkswkct0.
Share:
References :
- Techmeme: Retro Biosciences, the Sam Altman-backed startup that wants to use AI to develop therapies for extending human lifespan by a decade, is raising a $1B Series A (Financial Times)
- SiliconANGLE: Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
- siliconangle.com: Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
- www.ft.com: Retro Biosciences, the Sam Altman-backed startup that wants to use AI to develop therapies for extending human lifespan by a decade, is raising a $1B Series A
- TechCrunch: Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
- www.techmeme.com: Retro Biosciences, the Sam Altman-backed startup that wants to use AI to develop therapies for extending human lifespan by a decade, is raising a $1B Series A (Financial Times)
- Techmeme: Retro Biosciences, the Sam Altman-backed startup that wants to use AI to develop therapies for extending human lifespan by a decade, is raising a $1B Series A (Financial Times)
Classification:
- HashTags: #RetroBio #AIdrugs #Longevity
- Company: Retro Biosciences
- Product: AI-driven therapies
- Feature: drug discovery
- Type: Research
- Severity: Informative